Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies: Influence of Differences in Modeling Methods on Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies: Influence of Differences in Modeling Methods on Outcomes

Published:2012-01 Issue:1 Volume:15 Page:94-105
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Frederix Gerardus W.J.,Severens Johan L.,Hövels Anke M.,Raaijmakers Jan A.M.,Schellens Jan H.M.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference56 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up;Kataja;Ann Oncol,2009

3. Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: an economic evaluation;Dedes;Eur J Cancer,2009

4. Cost-effectiveness analysis of lapatinib in HER-2-positive advanced breast cancer;Le;Cancer,2009

5. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?;Eichler;Value Health,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation;BMC Health Services Research;2023-06-26

2. Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature;JNCI Monographs;2022-07-01

3. Economic evaluations of oral medications for breast cancer treatment in the U.S.: a systematic review with a focus on cost-effectiveness threshold;Expert Review of Pharmacoeconomics & Outcomes Research;2019-10-25

4. Health Technology Assessment Challenges in Oncology: 20 Years of Value in Health;Value in Health;2019-05

5. Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review;PLOS ONE;2018-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3